LVY: S-Lenalidomide
LVY is a Ligand Of Interest in 4V30 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 4V30_LVY_B_151 | 90% | 2% | 0.079 | 0.961 | 2.7 | 4.23 | 5 | 12 | 0 | 0 | 100% | 1 |
| 4V30_LVY_A_151 | 75% | 2% | 0.101 | 0.935 | 2.97 | 3.49 | 4 | 10 | 0 | 0 | 100% | 1 |
| 4V30_LVY_C_151 | 20% | 2% | 0.219 | 0.821 | 3.33 | 3.41 | 5 | 10 | 0 | 0 | 100% | 1 |
| 5FQD_LVY_B_1438 | 74% | 13% | 0.15 | 0.98 | 1.26 | 2.62 | 1 | 13 | 1 | 0 | 100% | 1 |
| 4CI2_LVY_B_1429 | 60% | 30% | 0.184 | 0.97 | 0.86 | 1.89 | - | 6 | 0 | 0 | 100% | 1 |
| 4TZ4_LVY_C_502 | 58% | 9% | 0.188 | 0.967 | 1.73 | 2.7 | 5 | 10 | 0 | 0 | 100% | 1 |
| 8RQA_LVY_A_501 | 48% | 64% | 0.123 | 0.864 | 0.45 | 0.91 | - | 2 | 2 | 0 | 100% | 1 |
